Map Shows States With Impacted IV As Fiberglass Detected in Saline
Baxter recalled saline IV bags distributed to 14 states after potential fiberglass contamination was detected.
Baxter International has voluntarily recalled two lots of 0.9% Sodium Chloride Injection in the United States due to the potential presence of fiberglass particulate matter in the saline solution. The FDA was notified of the recall, which affects products distributed in 14 states between July 31 and August 3, 2026. The affected saline solution is commonly used as a source of water and electrolytes in intravenous treatments and as a priming solution in hemodialysis procedures.
Baxter stated that the recalled products were distributed from July 31 to August 3, 2026, with an expiration date of October 31, 2027. Both lots have a volume of 500 ml in a VIAFLEX Plastic Container. The FDA warned that fiberglass particles in an IV solution may lead to serious health risks if administered intravenously, including blockages and clotting in blood vessels, pulmonary embolism, permanent organ damage, or death.
Baxter has not received any complaints or reports of adverse events related to this issue. Customers have been notified of the recall and have received instructions on how to identify and return the affected products. Baxter is contacting customers by email to provide further instructions. The FDA has been informed of the recall.
Written by urgent.news from Newsweek's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
